Pharmalys completes another successful GCLP surveillance audit at the Medical Research Council Unit, The Gambia

May 29, 2026 | GCLP Accreditation Scheme

Pharmalys is pleased to announce the successful completion of a Good Clinical Laboratory Practice (GCLP) surveillance audit at the Medical Research Council Unit in The Gambia, conducted from 11 to 18 May 2026 across the Fajara, Basse, and Keneba locations.

The audit was led by Pharmalys GCLP Consultant, Beatrice, and focused on evaluating continued compliance with GCLP standards across the institution’s laboratory and quality systems. The assessment covered operational procedures, quality management practices, documentation standards, staff competency, and adherence to international clinical laboratory requirements.

The successful outcome reflects the ongoing commitment of the institution to maintaining high quality laboratory operations that support internationally recognised clinical research standards.

During the visit, Beatrice met with key members of the leadership and quality teams, including the newly appointed Director, Ed Clarke, Dr Ousman Secka, the Head of Laboratories and the Head of Quality & Risk Management, Yai Louise Ndure Bensouda (photographed above). Their continued support and dedication to quality systems were instrumental in the success of the surveillance audit.

Pharmalys congratulates all staff involved for their professionalism, preparation, and commitment to continuous improvement throughout the audit process.

Find out more about the GCLP accreditation scheme at Pharmalys.

Pharmalys corporate social responsibility commitments

Pharmalys corporate social responsibility commitments

Pharmalys’ approach to corporate social responsibility reflects its long-standing commitment to advancing clinical research while contributing to sustainable and inclusive healthcare systems, particularly across the African continent. Structured around three core...

A recap from the first Pharmalys Voice of 2026

A recap from the first Pharmalys Voice of 2026

On 26 March 26 2026, Pharmalys held its first Pharmalys Voice meeting of the year, bringing together colleagues from across the company for an engaging and interactive virtual session. With a mix of insightful presentations, lively discussions and moments of fun, the...

Women’s economic power benefits everyone

Women’s economic power benefits everyone

Gender equality is a core challenge to be met. More than 95% of women worldwide live in economies that do not provide full legal equality. Even in economies that have modernised their laws, women still face constraints that limit the work they can do, the businesses...

Microplastics and human health: A growing public health concern

Microplastics and human health: A growing public health concern

Developed following the 19th century Industrial Revolution, plastics are synthetic or semi-synthetic polymers, categorised according to the chemical composition of their primary polymer and any side chains. These include acrylics, polyesters, silicones, polyethylenes...

A successful GCLP Audit at Institut Pasteur de Dakar, Senegal

A successful GCLP Audit at Institut Pasteur de Dakar, Senegal

Jeanette Young’s unit at Pharmalys plays a crucial role in advancing global excellence in Good Clinical Laboratory Practice (GCLP) through the delivery of highly specialised ad hoc services, including tailored GCLP trainings and comprehensive gap analyses for...

Delivering excellence under complexity: Lessons learnt from Africa

Delivering excellence under complexity: Lessons learnt from Africa

Pharmalys is an international Clinical Research Organisation (CRO) with a diverse team distributed across Europe, Asia, North America and Africa. Within our global portfolio, we support the execution of numerous clinical trials (CTs) in Africa. Across these projects,...